Literature DB >> 6130702

Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features.

G Mazoujian, G S Pinkus, S Davis, D E Haagensen.   

Abstract

Gross cystic disease fluid is a pathologic secretion from breast composed of several glycoproteins, including a unique 15,000-dalton monomer protein, GCDFP-15. By the immunoperoxidase technique, GCDFP-15 was localized in the apocrine metaplastic epithelium lining breast cysts and in apocrine glands in the axilla, vulva, eyelid, and ear canal. In normal breast tissue, a few individual epithelial cells within lobules and small ducts were focally positive for GCDFP-15. Fourteen of 30 breast carcinomas stained positively for GCDFP-15. Of 16 carcinomas with apocrine features, 12 stained positively. Benign and malignant lesions from other tissues, including lung, colon, ovary, endometrium, stomach, prostate, liver, esophagus, and kidney, revealed no immunoreactivity. The only cells of "non-apocrine" tissues that contained GCDFP-15 were serous cells of the submandibular salivary gland, submucosal glands of the bronchi, and accessory lacrimal glands. Phylogenetically, these tissues have biologic features in common with apocrine glands. This report is the first to characterize GCDFP-15 as a specific tissue marker of apocrine epithelium.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6130702      PMCID: PMC1916150     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  24 in total

1.  Apocrine metaplasia in cystic hyperplastic mastopathy. Histochemical and ultrastructural observations.

Authors:  A Ahmed
Journal:  J Pathol       Date:  1975-04       Impact factor: 7.996

2.  The physiology of the human axillary apocrine sweat gland.

Authors:  W B SHELLEY; H J HURLEY
Journal:  J Invest Dermatol       Date:  1953-04       Impact factor: 8.551

3.  An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.

Authors:  S R Wellings; H M Jensen; R G Marcum
Journal:  J Natl Cancer Inst       Date:  1975-08       Impact factor: 13.506

4.  A specific progesterone-binding component of human breast cyst fluid.

Authors:  W H Pearlman; J L Guériguian; M E Sawyer
Journal:  J Biol Chem       Date:  1973-08-25       Impact factor: 5.157

5.  The control of the apocrine glands of the rabbit by steroid hormones.

Authors:  N A Wales; F J Ebling
Journal:  J Endocrinol       Date:  1971-12       Impact factor: 4.286

6.  Electron microscopic study of apocrine secretion.

Authors:  K Hashimoto; B G Gross; W F Lever
Journal:  J Invest Dermatol       Date:  1966-04       Impact factor: 8.551

7.  Accumulation of hormones in breast cyst fluid.

Authors:  H L Bradlow; M K Schwartz; M Fleisher; J S Nisselbaum; R Boyar; J O'Connor; D K Fukushima
Journal:  J Clin Endocrinol Metab       Date:  1979-11       Impact factor: 5.958

8.  Chronic mastitis and carcinoma of the breast.

Authors:  R R Monson; S Yen; B MacMahon
Journal:  Lancet       Date:  1976-07-31       Impact factor: 79.321

9.  Apocrine differentiation in human mammary carcinoma.

Authors:  J A Mossler; T K Barton; A D Brinkhous; K S McCarty; J A Moylan; K S McCarty
Journal:  Cancer       Date:  1980-12-01       Impact factor: 6.860

10.  Evaluation of a breast cyst fluid protein detectable in the plasma of breast carcinoma patients.

Authors:  D E Haagensen; G Mazoujian; W D Holder; S J Kister; S A Wells
Journal:  Ann Surg       Date:  1977-03       Impact factor: 12.969

View more
  47 in total

1.  Mixed apocrine/endocrine ductal carcinoma in situ of the breast coexistent with lobular carcinoma in situ.

Authors:  J D Coyne; P A Dervan; L Barr; A D Baildam
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

2.  Histiocytoid Breast Carcinoma: A Case Report with Immunohistochemical and Ultrastructural Studies.

Authors: 
Journal:  Breast Cancer       Date:  1996-03-29       Impact factor: 4.239

Review 3.  Biochemical study of cyst fluid in human breast cystic disease: a review.

Authors:  C L Enriori; J E Novelli; M del C Cremona; R J Hirsig; P J Enriori
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

4.  Mutagens in human breast cyst fluid.

Authors:  W N Scott; W R Miller
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

5.  Unusual N-type glycosylation of salivary prolactin-inducible protein (PIP): multiple LewisY epitopes generate highly-fucosylated glycan structures.

Authors:  Alena Wiegandt; Henning N Behnken; Bernd Meyer
Journal:  Glycoconj J       Date:  2018-06-01       Impact factor: 2.916

Review 6.  A perspective of comparative salivary and breast pathology. Part I: microstructural aspects, adaptations and cellular events.

Authors:  Asterios Triantafyllou; Jennifer L Hunt; Kenneth O Devaney; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-05-07       Impact factor: 2.503

7.  Progesterone binding cyst protein (PBCP) in primary breast cancer: a new prognostic factor?

Authors:  J A Søreide; O A Lea; S Kvinnsland
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

8.  Androgen metabolism and apocrine differentiation in human breast cancer.

Authors:  W R Miller; J Telford; J M Dixon; A A Shivas
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

9.  Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.

Authors:  Guillaume Banneau; Mickaël Guedj; Gaëtan MacGrogan; Isabelle de Mascarel; Valerie Velasco; Renaud Schiappa; Valerie Bonadona; Albert David; Catherine Dugast; Brigitte Gilbert-Dussardier; Olivier Ingster; Pierre Vabres; Frederic Caux; Aurelien de Reynies; Richard Iggo; Nicolas Sevenet; Françoise Bonnet; Michel Longy
Journal:  Breast Cancer Res       Date:  2010-08-16       Impact factor: 6.466

10.  Hepatic clearance and metabolism in the rat of a human breast cancer associated glycoprotein (GCDFP-15).

Authors:  C A Toth; D E Haagensen; S Davis; N Zamcheck; P Thomas
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.